The popularization of anti-obesity drugs has affected nearly every medical specialty
In good news, a recent study found that taking the medication semaglutide had a 20% lower risk of heart attack, stroke, or death due to cardiovascular disease
According to a 2019 survey by the American Society of Plastic Surgeons (ASPS), non-surgical cosmetic procedures, including peptide therapies, witnessed a staggering 15% increase in popularity over the previous year [1]
Generally in the U.S., healthcare technologies and services are considered cost-effective if theyre below $150,000 per QALY
The pathways include inflammation, vascular damage, mitochondrial dysfunction, the effects of insulin resistance (IR) on metabolism in the brain, the formation of advanced glycation end products (AGEs), and the aggregation of pathological proteins such as A and -synuclein [12]
One is a scalpel, the other is a high-tech multi-tool